97 related articles for article (PubMed ID: 26205155)
1. Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy.
Jacobsen C; Oechsle K; Hauschild J; Steinemann G; Spath B; Bokemeyer C; Ruf W; Honecker F; Langer F
Thromb Res; 2015 Sep; 136(3):673-81. PubMed ID: 26205155
[TBL] [Abstract][Full Text] [Related]
2. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
3. Activity of nintedanib in germ cell tumors.
Steinemann G; Jacobsen C; Gerwing M; Hauschild J; von Amsberg G; Höpfner M; Nitzsche B; Honecker F
Anticancer Drugs; 2016 Feb; 27(2):89-98. PubMed ID: 26479145
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
[TBL] [Abstract][Full Text] [Related]
5. Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines.
Mayer F; Mueller S; Malenke E; Kuczyk M; Hartmann JT; Bokemeyer C
Invest New Drugs; 2005 Jun; 23(3):205-11. PubMed ID: 15868376
[TBL] [Abstract][Full Text] [Related]
6. The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines.
Perry J; Powles T; Shamash J; Veerupillai A; McGrowder E; Noel E; Lu YJ; Oliver T; Joel S
Cancer Chemother Pharmacol; 2009 Oct; 64(5):925-33. PubMed ID: 19263053
[TBL] [Abstract][Full Text] [Related]
7. Seladin-1 and testicular germ cell tumours: new insights into cisplatin responsiveness.
Nuti F; Luciani P; Marinari E; Erdei E; Bak M; Deledda C; Rosati F; Mazzinghi B; Danza G; Stoop H; Looijenga LH; Peri A; Serio M; Krausz C
J Pathol; 2009 Dec; 219(4):491-500. PubMed ID: 19844922
[TBL] [Abstract][Full Text] [Related]
8. 5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor Cells.
Oing C; Verem I; Mansour WY; Bokemeyer C; Dyshlovoy S; Honecker F
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577584
[TBL] [Abstract][Full Text] [Related]
9. Anthracycline treatment of the human monocytic leukemia cell line THP-1 increases phosphatidylserine exposure and tissue factor activity.
Boles JC; Williams JC; Hollingsworth RM; Wang JG; Glover SL; Owens AP; Barcel DA; Kasthuri RS; Key NS; Mackman N
Thromb Res; 2012 Feb; 129(2):197-203. PubMed ID: 21762960
[TBL] [Abstract][Full Text] [Related]
10. Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia.
Tsunaka M; Shinki H; Koyama T
PLoS One; 2017; 12(4):e0175765. PubMed ID: 28406995
[TBL] [Abstract][Full Text] [Related]
11. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model.
Jørgensen A; Blomberg Jensen M; Nielsen JE; Juul A; Rajpert-De Meyts E
J Steroid Biochem Mol Biol; 2013 Jul; 136():238-46. PubMed ID: 23098692
[TBL] [Abstract][Full Text] [Related]
12. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
13. Micro-RNA expression in cisplatin resistant germ cell tumor cell lines.
Port M; Glaesener S; Ruf C; Riecke A; Bokemeyer C; Meineke V; Honecker F; Abend M
Mol Cancer; 2011 May; 10():52. PubMed ID: 21575166
[TBL] [Abstract][Full Text] [Related]
14. The Role of
Timmerman DM; Eleveld TF; Gillis AJM; Friedrichs CC; Hillenius S; Remmers TL; Sriram S; Looijenga LHJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769213
[TBL] [Abstract][Full Text] [Related]
15. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
16. Repression of cyclin D1 as a target for germ cell tumors.
Freemantle SJ; Vaseva AV; Ewings KE; Bee T; Krizan KA; Kelley MR; Hattab EM; Memoli VA; Black CC; Spinella MJ; Dmitrovsky E
Int J Oncol; 2007 Feb; 30(2):333-40. PubMed ID: 17203214
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the molecular effects of romidepsin on germ cell tumours: DHRS2 is involved in cell cycle arrest but not apoptosis or induction of romidepsin effectors.
Nettersheim D; Berger D; Jostes S; Skowron M; Schorle H
J Cell Mol Med; 2019 Jan; 23(1):670-679. PubMed ID: 30460772
[TBL] [Abstract][Full Text] [Related]
18. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours.
Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL
Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
20. [Effects of tetramethylpyrazine on thrombin-induced tissue factor expression in vascular endothelial cells].
Cheng CY; Sun Y; Wen ZB; He XF; Wang GF; Lin GQ; Jiang HH; Tian XM; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1743-7. PubMed ID: 19726327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
